WHO
REGULATORY UPDATE
Ipca’s Primaquine pediatric products prequalified
Published: 11/2/2026Detected: 9/28/2026
Summary preview
Adds three pediatric primaquine (phosphate) tablet strengths (2.5 mg, 5 mg, 7.5 mg) from Ipca, India, to the WHO Prequalification Programme list, indicating WHO PQ acceptance for use in preventing relapse of Plasmodium…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
pediatrics
manufacturing
quality
clinical
safety
labeling
#WHO prequalification
#primaquine
#primaquine phosphate
#pediatric
Official Source Document Source Verified
Access the original document directly from WHO.